BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 17241181)

  • 1. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
    J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
    Nilsson PM; Engström G; Hedblad B
    Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis.
    Panagiotakos DB; Pitsavos C; Das UN; Skoumas Y; Stefanadis C
    Diabetes Obes Metab; 2007 Sep; 9(5):660-8. PubMed ID: 17697058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people.
    Kim HM; Kim DJ; Jung IH; Park C; Park J
    Diabetes Res Clin Pract; 2007 Jul; 77(1):99-106. PubMed ID: 17118477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The longitudinal effects of physical activity history on metabolic syndrome.
    Yang X; Telama R; Hirvensalo M; Mattsson N; Viikari JS; Raitakari OT
    Med Sci Sports Exerc; 2008 Aug; 40(8):1424-31. PubMed ID: 18614950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults.
    Unwin N; Bhopal R; Hayes L; White M; Patel S; Ragoobirsingh D; Alberti G
    Ethn Dis; 2007; 17(3):522-8. PubMed ID: 17985508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in connection with BMI in young Finnish male adults.
    Mikkola I; Keinänen-Kiukaanniemi S; Laakso M; Jokelainen J; Härkönen P; Meyer-Rochow VB; Juuti AK; Peitso A; Timonen M
    Diabetes Res Clin Pract; 2007 Jun; 76(3):404-9. PubMed ID: 17064807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria.
    Harzallah F; Alberti H; Ben Khalifa F
    Diabet Med; 2006 Apr; 23(4):441-4. PubMed ID: 16620275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.